- Home
- EMD vs AUTL Comparison
EMD vs AUTL Comparison
Compare EMD & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- AUTL
- Stock Information
- Founded
- EMD 2003
- AUTL 2014
- Country
- EMD United States
- AUTL United Kingdom
- Employees
- EMD N/A
- AUTL N/A
- Industry
- EMD Finance/Investors Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EMD Finance
- AUTL Health Care
- Exchange
- EMD Nasdaq
- AUTL Nasdaq
- Market Cap
- EMD 581.9M
- AUTL 625.4M
- IPO Year
- EMD N/A
- AUTL 2018
- Fundamental
- Price
- EMD $10.10
- AUTL $2.49
- Analyst Decision
- EMD
- AUTL Strong Buy
- Analyst Count
- EMD 0
- AUTL 5
- Target Price
- EMD N/A
- AUTL $9.32
- AVG Volume (30 Days)
- EMD 248.5K
- AUTL 1.5M
- Earning Date
- EMD 01-01-0001
- AUTL 08-12-2025
- Dividend Yield
- EMD 10.25%
- AUTL N/A
- EPS Growth
- EMD N/A
- AUTL N/A
- EPS
- EMD N/A
- AUTL N/A
- Revenue
- EMD N/A
- AUTL $9,011,000.00
- Revenue This Year
- EMD N/A
- AUTL $471.17
- Revenue Next Year
- EMD N/A
- AUTL $115.34
- P/E Ratio
- EMD N/A
- AUTL N/A
- Revenue Growth
- EMD N/A
- AUTL N/A
- 52 Week Low
- EMD $7.85
- AUTL $1.11
- 52 Week High
- EMD $9.55
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- EMD 54.25
- AUTL 55.47
- Support Level
- EMD $10.00
- AUTL $2.33
- Resistance Level
- EMD $10.13
- AUTL $2.69
- Average True Range (ATR)
- EMD 0.07
- AUTL 0.16
- MACD
- EMD -0.02
- AUTL -0.02
- Stochastic Oscillator
- EMD 45.45
- AUTL 43.24
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.